171 related articles for article (PubMed ID: 331616)
1. Bartter's syndrome.
Bartter FC
Urol Clin North Am; 1977 Jun; 4(2):253-61. PubMed ID: 331616
[TBL] [Abstract][Full Text] [Related]
2. A familial disorder with hypokalemic alkalosis, hyperreninemia, aldosteronism, high urinary prostaglandins and normal blood pressure that is not "Bartter's syndrome".
Güllner HG; Gill JR; Bartter FC; Chan JC; Dickman PS
Trans Assoc Am Physicians; 1979; 92():175-88. PubMed ID: 398615
[No Abstract] [Full Text] [Related]
3. Hypokalemic alkalosis, hyperreninemia, aldosteronism, normal blood pressure and normal juxtaglomerular apparatus--a new syndrome of renal alkalosis.
Barakat AY; Francis YK; Mufarrij AA
Int J Pediatr Nephrol; 1986; 7(2):99-100. PubMed ID: 3522459
[TBL] [Abstract][Full Text] [Related]
4. Urinary kallikrein excretion in Bartter's syndrome.
Lechi A; Covi G; Lechi C; Mantero F; Scuro LA
J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
[TBL] [Abstract][Full Text] [Related]
5. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
Norby L; Mark AL; Kaloyanides GJ
Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
[TBL] [Abstract][Full Text] [Related]
6. Bartter's syndrome. New insights into pathogenesis and treatment.
Solomon RJ; Brown RS
Am J Med; 1975 Oct; 59(4):575-83. PubMed ID: 1166859
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome.
Bartter FC; Gill JR; Frolich JC; Bowden RE; Hollifield JW; Radfar N; Keiser HR; Oates JA; Seyberth H; Taylor AA
Trans Assoc Am Physicians; 1976; 89():77-91. PubMed ID: 828345
[TBL] [Abstract][Full Text] [Related]
8. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
Horký K; Schreiber V; Dvoráková J
Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
[TBL] [Abstract][Full Text] [Related]
9. The role of prostaglandins in Bartter's syndrome.
Winterborn MH; Hewitt GJ; Mitchell MD
Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
[TBL] [Abstract][Full Text] [Related]
10. Hypokalemic metabolic alkalosis--three case reports.
Galesić K; Bozić B; Sćukanec-Spoljar M; Morović-Vergles J; Cvitković-Kuzmić A; Ljubanović D
Acta Med Croatica; 2001; 55(4-5):219-23. PubMed ID: 12398028
[TBL] [Abstract][Full Text] [Related]
11. The syndrome of juxtaglomerular hyperplasia with aldosteronism, hypokalemic alkalosis and normal blood pressure.
Bartter FC
Birth Defects Orig Artic Ser; 1974; 10(4):104-8. PubMed ID: 4470884
[TBL] [Abstract][Full Text] [Related]
12. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Yoshinaga K; Saito T; Kabuki J
Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582
[TBL] [Abstract][Full Text] [Related]
13. Bartter's syndrome: physiological and pharmacological studies.
Delaney VB; Oliver JF; Simms M; Costello J; Bourke E
Q J Med; 1981; 50(198):213-32. PubMed ID: 6171004
[TBL] [Abstract][Full Text] [Related]
14. Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
Rodriguez-Soriano J; Vallo A; Oliveros R
Helv Paediatr Acta; 1978 Jun; 33(2):141-51. PubMed ID: 659258
[TBL] [Abstract][Full Text] [Related]
15. [A case with Bartter's syndrome associated with type II hyperlipidemia, increased fluidity of plasma VLDL and abnormal configuration of peripheral erythrocytes (author's transl)].
Imai T; Makino K; Takeda N; Nakamura S; Endo Y; Okuyama M; Miura K; Iida H; Kawade M
Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):131-47. PubMed ID: 7044842
[TBL] [Abstract][Full Text] [Related]
16. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
Simatupang TA; Radó JP; Boer P; Geyskes GG; Vos J; Dorhout Mees EJ
Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):14-8. PubMed ID: 631965
[TBL] [Abstract][Full Text] [Related]
18. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
Gill JR; Frölich JC; Bowden RE; Taylor AA; Keiser HR; Seyberth HW; Oates JA; Bartter FC
Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
[TBL] [Abstract][Full Text] [Related]
20. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
